ARX — Aroa Biosurgery Income Statement
0.000.00%
Last trade - 00:00- AU$246.60m
- AU$232.71m
- NZ$84.70m
- 80
- 64
- 72
- 83
Annual income statement for Aroa Biosurgery, fiscal year end - March 31st, NZD millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 22.3 | 39.7 | 63.4 | 69.1 | 84.7 |
| Cost of Revenue | |||||
| Gross Profit | 15.5 | 30.3 | 53.5 | 59 | 72.6 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 40.3 | 47.3 | 66.5 | 79.7 | 87.6 |
| Operating Profit | -18 | -7.64 | -3.11 | -10.7 | -2.92 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -19.1 | -8.26 | -0.384 | -10.4 | -3.25 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -19.2 | -8.39 | -0.396 | -10.6 | -3.81 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -19.2 | -8.39 | -0.396 | -10.6 | -3.81 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -19.2 | -8.39 | -0.396 | -10.6 | -3.81 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.064 | -0.025 | -0.001 | -0.031 | -0.011 |